Main Management ETF Advisors, LLC

SEC CIK: 0001698607
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by Main Management ETF Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overview All 13F holders of LGND Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2025

Holdings of LGND by Main Management ETF Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−7,330−100.0%	Sold out	Holders
Q2 2025	7,330	$833.0K	<0.1%	+120+1.7%	Added	Holders
Q1 2025	7,210	$758.0K	<0.1%	+7,210	New	Holders